(lp0
S'Prothena Corporation plc : Prothena Announces Public Offering of Ordinary Shares Yahoo Finance - Mar 2, 2017 DUBLIN, Ireland, March 02, 2017  -- Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced that&nbsp;...'
p1
aS'Prothena Corporation plc  Soars 8.53% on February 27 Equities.com - Feb 27, 2017 Prothena Corporation plc  had a good day on the market for Monday February 27 as shares jumped 8.53% to close at $58.01.Notable Price Swings: Prothena Corporation plc  - Is storiesBrokerages Set Prothena Corporation PLC  Price Target at $76.00 - The Cerbat Gem'
p2
aS'Prothena Corporation plc  Plunges 5.49% on March 07 Equities.com - Mar 7, 2017 Prothena Corporation plc  had a rough trading day for Tuesday March 07 as shares tumbled 5.49%, or a loss of $-3.01 per share, to close at $51.85.Prothena Co. PLC  Research Coverage Started at Instinet - Chaffey Breeze'
p3
aS'Prothena Corporation plc  Plunges 7.09% on March 03 Equities.com - Mar 3, 2017 Prothena Corporation plc  had a rough trading day for Friday March 03 as shares tumbled 7.09%, or a loss of $-4.26 per share, to close at $55.81.'
p4
aS'Prothena Corporation plc  Moves Lower on Volume Spike for March 17 Equities.com - Mar 17, 2017 Prothena Corporation plc  traded on unusually high volume on Mar. 17, as the stock lost 0.55% to close at $53.89. On the day, Prothena Corporation plc saw 543,071 shares trade hands on 3,132 trades. Considering that the stock averages only a ...Next Weeks Broker Price Targets For Prothena Corporation Plc  - Fiscal StandardProthena Co. PLC - Receive News &amp; Ratings Daily - BBNS'
p5
aS'Broker Outlook For The Week Ahead Prothena Corporation Plc  Fiscal Standard - 21 hours ago Currently 10 analysts have outstanding research reports on Prothena Corporation plc , according to the reports 5 analysts rate the stock Buy, 5 Outperform, 0 Underperform, 0 Sell, while 0 Hold.Instinet Initiates Coverage on Prothena Co. PLC  - Chaffey BreezeLatest Stocks: The Prothena Co. PLC  Stock Rating Reaffirmed by ... - Petro Global News 24'
p6
aS"Prothena Corporation plc  QI &amp; Valuation Watch Business Review - Mar 28, 2017 Prothena Corporation plc  currently has a Q.i. Value of 77.00000. Checking in on some valuation rankings, Prothena Corporation plc  has a Value Composite score of 92. Developed by James O'Shaughnessy, the VC&nbsp;..."
p7
aS'Prothena Corporation plc  Plunges 6.53% on March 21 Equities.com - Mar 21, 2017 Prothena Corporation plc  had a rough trading day for Tuesday March 21 as shares tumbled 6.53%, or a loss of $-3.55 per share, to close at $50.79.$0.20 EPS Expected for NCI , 8 Analysts Covering Prothena PLC  - Wolcott DailyIntraday Movers: Prothena Corporation plc  , Nomad Foods Limited ... - NYSE Journal '
p8
aS'Prothena Announces Appointment of Chief Regulatory Officer GlobeNewswire  - Dec 15, 2016 DUBLIN, Ireland, Dec. 15, 2016  -- Prothena Corporation plc , a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, announced&nbsp;...'
p9
aS'Street Analyst Thoughts on Shares of Prothena Corporation plc  Melville Review - 15 hours ago Covering sell-side analysts currently have a consensus stock rating of 1 on shares of Prothena Corporation plc .'
p10
a.